Abstract
Block copolymers spontaneously assemble into nanoscaled polymeric micelles, which have significant potential as drug carriers. Following much work in related fields over the last decade, a drug carrier based on polymeric micelles has been created. Advances in polymer chemistry have significantly contributed to progress in polymeric micelle-based drug carrier research, because the micelle parameters that are most important to successful drug delivery can be modulated by engineering the structures of the micelle-forming block copolymers. More intelligent polymeric micelles enabling environmentally-sensitive drug release and cell type-specific targeting have also recently emerged and have attracted increasing interest in the field of polymer chemistry. This paper therefore reviews recent progress in research on polymeric micelles for drug delivery, focusing upon the relationship between the chemical design of polymeric micelles and their physicochemical and biological properties.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- ADR:
-
Adriamycin
- AFM:
-
Atomic force microscopy
- AmB:
-
Amphotericin B
- ASGP:
-
Asialoglycoprotein
- BPEI:
-
Branched polyethyleneimine
- CDDP:
-
cis-Diamminedichloroplatinum(II), cisplatin
- CL:
-
ε-Caprolactone
- CMC:
-
Critical micelle concentration
- CNV:
-
Choroidal neovascularization
- DDS:
-
Drug delivery system
- DMAc:
-
N,N-Dimethylacetamide
- DPT:
-
Dipropylene triamine
- EO:
-
Ethylene oxide
- EPR effect:
-
Enhanced permeability and retention effect
- FDA:
-
Food and Drug Administration
- GA:
-
Glycolic acid
- LCST:
-
Lower critical solution temperature
- LPEI:
-
Linear polyethyleneimine
- NCA:
-
N-carboxyanhydride
- ODN:
-
Oligonucleotides
- PCL:
-
Poly(ε-caprolactone)
- PDLLA:
-
Poly(d,l-lactide)
- pDNA:
-
Plasmid DNA
- PEO:
-
Poly(ethylene oxide)
- PEO-b-ODN:
-
PEO-b-oligonucleotide
- PEO-b-DPT:
-
PEO-b-poly(3-[(3-aminopropyl)amino]propylaspartamide)
- PEO-b-PAAs:
-
PEO-b-poly(amino acids)
- PEO-b-PAMA:
-
PEO-b-poly[(2-dimethylamino)ethyl methacrylate]
- PEO-P(Asp-ADR):
-
PEO-b-poly(α,β-aspartic acid)
- PEO-b-P(Asp):
-
Adriamycin-conjugated PEO-b-P(Asp)
- PEO-b-P(Asp-Hyd):
-
PEO-b-P(Asp) processing the hydrazide groups in the side chains
- PEO-b-PBLA:
-
PEO-b-poly(β-benzyl l-aspartate)
- PEO-b-PCL:
-
PEO-b-poly(ε-caprolactone)
- PEO-b-PDLLA:
-
PEO-b-poly(d,l-lactide)
- PEO-b-PE:
-
PEO-b-phosphatidylethanolamine
- PEO-b-PEE:
-
PEO-b-polyethylethylene
- PEO-b-P(Glu):
-
PEO-b-poly(glutamic acid)
- PEO-b-P(His):
-
PEO-b-poly(l-histidine)
- PEO-b-PLGA:
-
PEO-b-poly(lactide-co-glycolic acid)
- PEO-b-PLA:
-
PEO-b-poly(lactide)
- PEO-b-PLLA:
-
PEO-b-poly(l-lactide)
- PEO-b-P(Lys):
-
PEO-b-poly(l-lysine)
- PEO-b-P(Lys-IM):
-
PEO-b-P(Lys) that has the side chain partially substituted with a 1-imino-4-mercaptobutyl group
- PEO-b-P(Lys-MP):
-
PEO-b-P(Lys) that has the side chain partially substituted with a 3-mercaptopropionyl group
- PEO-b-P(Lys(Z)):
-
PEO-b-poly(ε-benzyloxycarbonyl l-lysine)
- PGA:
-
Poly(glycolic acid)
- P(His):
-
Poly(l-histidine)
- PIC:
-
Polyion complex
- PLA:
-
Poly(lactide)
- PLLA:
-
Poly(l-lactide)
- Pluronic:
-
PEO-b-poly(propylene oxide)-b-PEO
- P(Lys):
-
Poly(l-lysine)
- pNP:
-
p-Nitrophenylcarbonyl group
- RES:
-
Reticuloendothelial system
- siRNA:
-
Small interfering RNA
- SPDP:
-
3-(2-Pyridyldithio)propionate
- TEM:
-
Transmission electron microscopy
- T g :
-
Glass transition temperature
- 32(−)DP:
-
Third generation dendrimer with 32 carboxylic acid groups on the periphery
- 32(+)DP:
-
Third generation dendrimer with 32 quaternary trimethylamino groups on the periphery
References
Webber SE, Munk P, Tuzar Z (1996) Solvents and self-organization of polymers. NATO ASI Series. Kluwer Academic, London
Zhang L, Eisenberg A (1995) Science 268:1728
Moffitt M, Khougaz K, Eisenberg A (1996) Acc Chem Res 29:95
Schmolka IR (1977) J Am Oil Chem Soc 54:110
Bader H, Ringsdorf H, Schmidt B (1984) Angew Makromol Chem 123–124:457
Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y (1993) J Control Release 24:119
Kataoka K, Harada A, Nagasaki Y (2001) Adv Drug Deliv Rev 47:113
Kakizawa Y, Kataoka K (2002) Adv Drug Deliv Rev 54:203
Oh KT, Bronich TK, Kabanov AV (2004) J Control Release 94:411
Lavasanifar A, Samuel J, Kown G (2002) Adv Drug Deliv Rev 54:169
Allen C, Maysinger D, Eisenberg A (1999) Colloid Surf B Biointerfaces 16:3
Lukyanov AN, Torchilin VP (2004) Adv Drug Deliv Rev 56:1273
Torchilinn VP (1995) Adv Drug Deliv Rev 16:295
Kataoka K (1996) Targetable polymeric drugs (Ch 4). In: Park K (ed), Controlled drug delivery: the next generation. ACS, Washington, DC
Seymour LW, Duncan R, Strohalm J, Kopecek J (1987) J Biomed Mater Res 21:1341
Stolnik S, Illum L, Davis SS (1995) Adv Drug Deliv Rev 16:195
Mosqueria VCF, Legrand P, Gulik A, Bourdon O, Gref R, Labarre D, Barratt G (2001) Biomaterials 22:2967
Harris JM (1992) Introduction to biotechnical and biomedical applications of poly(ethylene glycol) (Ch 1). In: Harris JM (ed) Poly(ethylene glycol) chemistry: biotechnical and biomedical applications. Plenum, New York
Jeon SI, Lee JH, Andrade JD, De Gennes PG (1991) J Colloid Interf Sci 142:149
Matsumura Y, Maeda H (1986) Cancer Res 46:6387
Maeda H (2001) Adv Drug Deliv Rev 46:169
Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Am J Pathol 146:1029
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Proc Natl Acad Sci USA 95:4607
Jain RK (2001) Adv Drug Deliv Rev 46:149
Maeda H (2001) Adv Enzyme Regul 41:189
Wu J, Akaike T, Maeda H (1998) Cancer Res 58:159
Duncan R (2003) Nat Rev Drug Discov 2:347
Allen TM (2002) Nat Rev Cancer 2:750
Zhang X, Goosen MFA, Wys UP, Pichora D (1993) J Macromol Sci Rev Macromol Chem Phys C33:81
Morita T, Horiki Y, Suzuki T, Yoshino H (2001) Eur J Pharm Biopharm 51:45
Hiljanen-Vainio MP, Orava PA, Sepala JV (1997) J Biomed Mater Res 34:39
Ural E, Kesenci K, Fambri L, Migliaresi C, Piskin E (2000) Biomaterials 21:2147
Piskin E (1994) J Biomater Sci Polym Ed 6:775
Nakamura T, Hitomi S, Watanabe S, Shimizu Y, Jamshidi K, Hyon SH, Ikada Y (1989) J Biomed Mater Res 23:1115
Jamshidi K, Hyon SH, Ikada Y (1988) Polymer 29:2229
Nagasaki Y, Kutsuna T, Iijima M, Kato M, Kataoka K (1995) Bioconjug Chem 6:231
Akiyama Y, Nagasaki Y, Kataoka K (2004) Bioconjug Chem 15:424
Nagasaki Y, Iijima M, Kato M, Kataoka K (1995) Bioconjug Chem 6:702
Nakamura T, Nagasaki Y, Kataoka K (1998) Bioconjug Chem 9:300
Nagasaki Y, Okada T, Scholz C, Iijima M, Kato M, Kataoka K (1998) Macromolecules 31:1473
Iijima M, Nagasaki Y, Okada T, Kato M, Kataoka K (1999) Macromolecules 32:1140
Yasugi K, Nakamura T, Nagasaki Y, Kato M, Kataoka K (1999) Macromolecules 32:8024
Yamamoto Y, Nagasaki Y, Kato M, Kataoka K (1999) Colloids Surf B Biointerfaces 16:135
Tabuchi M, Ueda M, Kaji N, Yamasaki Y, Nagasaki Y, Yoshikawa K, Kataoka K, Baba Y (2004) Nat Biotechnol 22:337
Hernandez JR, Klok HA (2003) J Polym Sci A Polym Chem 41:1167
Yokoyama M, Inoue S, Kataoka K, Yui N, Sakurai Y (1987) Makromol Chem Rapid Commun 8:431
Yokoyama M, Inoue S, Kataoka K, Yui N, Sakurai Y (1989) Makromol Chem 190:2041
Harada A, Kataoka K (1995) Macromolecules 28:5294
Harada A, Cammas S, Kataoka K (1996) Macromolecules 29:6183
Kataoka K, Ishihara A, Harada A, Miyazaki H (1998) Macromolecules 31:6071
Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K (1993) Langmuir 9:945
Kwon GS, Naito M, Kataoka K, Yokoyama M, Sakurai Y, Okano T (1994) Colloids Surf B Biointerfaces 2:429
Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K (1995) Pharm Res 12:192
Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K (1997) J Control Release 48:195
Liaw J, Aoyagi T, Kataoka K, Sakurai Y, Okano T (1998) Pharm Res 15:1721
Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS (2000) J Control Release 64:143
Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin VP, Langer R (1994) Science 263:1600
La SB, Okano T, Kataoka K (1996) J Pharm Sci 85:85
Yamamoto Y, Yasugi K, Harada A, Nagasaki Y, Kataoka K (2002) J Control Release 82:359
Yokoyama M, Sugiyama T, Okano T, Sakurai Y, Naito M, Kataoka K (1993) Pharm Res 10:895
Kakizawa Y, Harada A, Kataoka K (1999) J Am Chem Soc 121:11247
Jaturanpinyo M, Harada A, Yuan X, Kataoka K (2004) Bioconjug Chem 15:344
Thurmond KBII, Kowalewski T, Wooley KL (1996) J Am Chem Soc 118:7239
Xu P, Tang H, Li S, Ren J, Kirk EV, Murdoch WJ, Radosz M, Shen Y (2004) Biomacromolecules 5:1736
Yasugi K, Nagasaki K, Kato M, Kataoka K (1999) J Control Release 62:89
Jule E, Yamamoto Y, Thouvenin M, Nagasaki Y, Kataoka K (2004) J Control Release 97:407
Kwon GS, Kataoka K (1995) Adv Drug Deliv Rev 16:295
Weissig V, Whiteman KR, Torchilin VP (1998) Pharm Res 15:1552
Lukyanov AN, Gao Z, Mazzola L, Torchilin VP (2002) Pharm Res 19:1424
Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K (2001) J Control Release 77:27
Kwon GS, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K (1994) J Contr Release 29:17
Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kataoka K (1999) J Drug Target 7:171
Nishiyama N, Okazaki S, Cabral H, Miyamoto M, Kato Y, Sugiyama Y, Nisho K, Matsumura Y, Kataoka K (2003) Cancer Res 63:8977
Uwatoku T, Shimokawa H, Abe K, Matsumoto Y, Hattori T, Oi K, Matsuda T, Kataoka K, Takeshita A (2003) Circ Res 92:e62
Lukyanov AN, Hartner WC, Torchilin VP (2004) J Control Release 94:187
Ideta R, Yanagi Y, Tamaki Y, Tasaka F, Harada A, Kataoka K (2004) FEBS Lett 557:21
Jeong YI, Cheon JB, Kim SH, Nah JW, Lee YM, Sung YK, Akaike T, Cho CS (1998) J Control Release 51:169
Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S (1990) Cancer Res 50:1693
Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K (1991) Cancer Res 51:3229
Yokoyama M, Okano T, Sakurai Y, Kataoka K (1994) J Control Release 32:269
Hamaguchi T, Matsumura Y, Shirao K, Shimada Y, Yamada Y, Muro K, Okusaka T, Ueno H, Ikeda M, Watanabe N (2003) 39th ASCO Annual Meeting, 31 May – 3 June 2003, Chicago, IL, Abs No. 571
Lavasanifar A, Samuel J, Kwon GS (2000) J Biomed Mater Res 52:831
Lavasanifar A, Samuel J, Kwon GS (2001) Colloids Surf B Biointerfaces 22:115
Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K (1998) J Control Release 55:219
Shuai X, Merdan T, Schaper AK, Xi F, Kissel T (2004) Bioconjug Chem 15:441
Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K (1999) Langmuir 15:377
Nishiyama N, Kato Y, Sugiyama Y, Kataoka K (2001) Pharm Res 18:1035
Aoyagi T, Sugi K, Sakurai Y, Okano T, Kataoka K (1999) Colloids Surf B Biointerfaces 16:237
Rapoport N, Pitt WG, Sun H, Nelson JL (2003) J Control Release 91:85
Kohori F, Sakai K, Aoyagi T, Yokoyama M, Yamato M, Sakurai Y, Okano T (1999) Colloids Surf B Biointerfaces 16:195
Bae YS, Fukushima S, Harada A, Kataoka K (2003) Angew Chem Int Edit 42:4640
Lee ES, Na Kun, Bae YH (2003) J Control Release 91:103
Nagasaki Y, Yasugi K, Yamamoto Y, Harada A, Kataoka K (2001) Biomacromolecules 2:1067
Jule E, Nagasaki Y, Kataoka K (2002) Langmuir 18:10334
Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B (2003) Proc Natl Acad Sci USA 100:6039
Torchilin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL, Rammohan R, Samokhin GP, Whiteman KR (2001) Biochim Biophys Acta 1511:397
Pan D, Turner JL, Wooley KL (2003) Chem Comm 19:2400
Liu J, Zhang Q, Remsen EE, Wooley KL (2001) Biomacromolecules 2:362
Becker ML, Remsen EE, Pan D, Wooley KL (2004) Bioconjug Chem 15:699
Savic R, Luo L, Eisenberg A, Maysinger D (2003) Science 300:615
Hamblin MR, Miller JL, Hasan T (2001) Cancer Res 61:7155
Batrakova EV, Han HY, Miller DW, Kabanov AV (1999) Pharm Res 15:1525
Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF (2001) J Pharmcol Exp Ther 296:551
Nishiyama N, Koizumi F, Okazaki S, Matsumura Y, Nishio K, Kataoka K (2003) Bioconjug Chem 14:449
Harada A, Kataoka K (1997) J Macromol Sci Pure Appl Chem A34:2119
Kabanov AV, Vinogradov SV, Suzdaltseva YG, Alakhov VY (1995) Bioconjug Chem 6:639
Kabanov AV, Kabanov VA (1998) Adv Drug Deliv Rev 30:49
Wolfert MA, Schacht EH, Toncheva V, Ulbrich K, Nazarova O, Seymour LW (1996) Hum Gene Ther 7:2123
Kataoka K, Togawa H, Harda A, Yasugi K, Matsumoto T, Katayose S (1996) Macromolecules 29:8556
Katayose K, Kataoka K (1997) Bioconjug Chem 8:702
Stapert HR, Nishiyama N, Jiang DL, Aida T, Kataoka K (2000) Langmuir 16:8182
Harada A, Kataoka K (1999) Science 283:65
Harada A, Kataoka K (2003) Macromolecules 36:4995
Harada A, Kataoka K (1998) Macromolecules 31:288
Harada A, Kataoka K (1999) Langmuir 15:4208
Harada A, Kataoka K (2001) J Control Release 72:85
Harada A, Kataoka K (2003) J Am Chem Soc 125:15306
Harada A, Kataoka K (1999) J Am Chem Soc 121:9241
Zauner W, Ogris M, Wagner E (1998) Adv Drug Deliv Rev 30:97
Merdan T, Kopecek J, Kissel (2002) Adv Drug Deliv Rev 54:715
Kabanov AV, Felgner PL, Seymour LW (1998) Self-assembling complexes for gene delivery from laboratory to clinical trial. Wiley, Chichester
Wu GY, Wu CH (1988) J Biol Chem 263:14621
Erbacher P, Roche AC, Monsigny M, Midoux P (1996) Exp Cell Res 225:186
Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) Proc Natl Acad Sci USA 92:7297
Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M (1997) Gene Ther 4:1100
Fischer D, Bieber T, Li Y, Elsasser HP, Kissel (1999) Pharm Res 16:1273
Itaka K, Harada H, Yamasaki Y, Nakamura K, Kawaguchi H, Kataoka K (2003) J Gene Med 6:76
Tang MX, Redemann CT, Szoka FC (1996) Bioconjug Chem 7:703
Sato T, Ishii T, Okahata Y (2001) Biomaterials 22:2075
Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS (1998) Pharm Res 15:1332
Ward CM, Read ML, Seymour LW (2001) Blood 97:2221
Boeckle S, von Gersdorff K, van der Piepen S, Culmsee C, Wagner E, Ogris M (2004) J Gene Med 6:1102
Toncheva V, Wolfert MA, Dash PR, Oupicky D, Ulblich K, Seymour LW, Schacht E (1998) Biochim Biophys Acta 1380:354
Itaka K, Yamauchi K, Harada A, Nakamura K, Kawaguchi H, Kataoka K (2003) Biomaterials 24:4495
Miyata K, Kakizawa Y, Nishiyama N, Harada A, Yamasaki Y, Koyama H, Kataoka K (2004) J Am Chem Soc 126:2355
Itaka K, Harada A, Nakamura K, Kawaguchi H, Kataoka K (2002) Biomacromolecules 3:841
Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K (2002) Gene Ther 9:407
Oupicky D, Carlisle RC, Seymour LW (2001) Gene Ther 8:713
Nah JW, Yu L, Han SO, Ann CH, Kim SW (2002) J Control Release 78:273
Vinogradov S, Batrakova E, Li S, Kabanov A (1999) Bioconjug Chem 10:851
Merdan T, Callahan J, Peterson H, Kunath K, Brakowsky U, Kopeckova P, Kissel T, Kopecek J (2003) Bioconjug Chem 14:989
Wakebayashi D, Nishiyama N, Yamasaki Y, Itaka K, Kanayama N, Harada A, Nagasaki Y, Kataoka K (2004) J Control Release 95:653
Kataoka K, Harada A, Wakebayashi D, Nagasaki Y (1999) Macromolecules 32:6892
Wakebayashi D, Nishiyama N, Itaka K, Miyata K, Yamasaki Y, Harada A, Koyama H, Nagasaki Y, Kataoka K (2004) Biomacromolecules 5:2128
Jeong JH, Kim SW, Park TG (2003) Bioconjug Chem 14:473
Oishi M, Sasaki S, Nagasaki Y, Kataoka K (2003) Biomacromolecules 4:1426
Jeong JH, Kim SW, Park TG (2003) J Control Release 93:183
Cheng JY, Wetering P, Talsma H, Crommelin DJA, Hennink WE (1996) Pharm Res 13:1038
Midoux P, Monsigny M (1999) Bioconjug Chem 10:406
Behr JP (1997) Chimia 51:34
Kabanov AV, Bronich TK, Kabanov VA, Yu K, Eisenberg A (1996) Macromolecules 29:6797
Itaka K, Kanayama N, Nishiyama N, Jang WD, Yamasaki Y, Nakamura K, Kawaguchi H, Kataoka K (2004) J Am Chem Soc 126:13612
Antonietti M, Forster S (2003) Adv Mater 15:1323
Discher DE, Eisenberg A (2002) Science 297:967
Ahmed F, Discher DE (2004) J Control Release 96:37
Lee JCM, Santore M, Bates FS, Discher DE (2002) Macromolecules 35:323
Lee JCM, Bermudez H, Discher BM, Sheehan MA, Won YY, Bates FS, Discher DE (2001) Biotechnol Bioeng 73:135
Graff A, Sauer M, Gelder PV, Meier W (2002) Proc Natl Acad Sci USA 99:5064
Dalhaimer P, Engler AJ, Parthasarathy R, Discher DE (2004) Biomacromolecules 5:1714
Dalhaimer P, Discher DE (2004) Abstracts, 228th ACS National Meeting, 22–26 August 2004, Philadelphia, PA, PMSE-431
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
About this chapter
Cite this chapter
Nishiyama, N., Kataoka, K. Nanostructured Devices Based on Block Copolymer Assemblies for Drug Delivery: Designing Structures for Enhanced Drug Function. In: Satchi-Fainaro, R., Duncan, R. (eds) Polymer Therapeutics II. Advances in Polymer Science, vol 193. Springer, Berlin, Heidelberg. https://doi.org/10.1007/12_025
Download citation
DOI: https://doi.org/10.1007/12_025
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29211-1
Online ISBN: 978-3-540-32449-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)